These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31677371)

  • 1. Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the "analytical quality by design" approach.
    Saha C; Gupta NV; Chandan RS
    Acta Pharm; 2020 Mar; 70(1):17-33. PubMed ID: 31677371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
    Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
    J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    Crommentuyn KM; Rosing H; Hillebrand MJ; Huitema AD; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):359-67. PubMed ID: 15081931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of simultaneous quantitative method of HIV protease inhibitors atazanavir, darunavir and ritonavir in human plasma by UPLC-MS/MS.
    Mishra T; Shrivastav PS
    ScientificWorldJournal; 2014; 2014():482693. PubMed ID: 24587725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography-tandem mass spectrometry following automated solid-phase extraction.
    Schuster A; Burzawa S; Jemal M; Loizillon E; Couerbe P; Whigan D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(2):377-86. PubMed ID: 12705978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of genotoxic impurity in atazanavir sulphate drug substance by LC-MS.
    K GB; K BMK; N S; D R; N VVSSR; B HB
    J Pharm Biomed Anal; 2017 Jan; 132():156-158. PubMed ID: 27723524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality by Design (QbD) Based Method for Estimation of Xanthohumol in Bulk and Solid Lipid Nanoparticles and Validation.
    Harish V; Almalki WH; Alshehri A; Alzahrani A; Gupta MM; Alzarea SI; Kazmi I; Gulati M; Tewari D; Gupta G; Dua K; Singh SK
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.
    Chitturi SR; Somannavar YS; Peruri BG; Nallapati S; Sharma HK; Budidet SR; Handa VK; Vurimindi HB
    J Pharm Biomed Anal; 2011 Apr; 55(1):31-47. PubMed ID: 21316175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma.
    Tribut O; Verdier MC; Arvieux C; Allain H; Michelet C; Bentué-Ferrer D
    Ther Drug Monit; 2005 Jun; 27(3):265-9. PubMed ID: 15905793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient HPLC method for the quantitative determination of atazanavir in human plasma suitable for bioequivalence and pharmacokinetic studies in healthy human subjects.
    Müller AC; Kanfer I
    J Pharm Biomed Anal; 2010 Sep; 53(1):113-8. PubMed ID: 20395105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring.
    Rezk NL; Crutchley RD; Yeh RF; Kashuba AD
    Ther Drug Monit; 2006 Aug; 28(4):517-25. PubMed ID: 16885719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography.
    Cateau E; Tournier N; Dupuis A; Le Moal G; Venisse N
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):791-5. PubMed ID: 15927437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection.
    Cattaneo D; Maggiolo F; Ripamonti D; Perico N
    J Chromatogr Sci; 2008 Jul; 46(6):485-9. PubMed ID: 18647467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a validated liquid chromatographic method for quantification of sorafenib tosylate in the presence of stress-induced degradation products and in biological matrix employing analytical quality by design approach.
    Sharma T; Khurana RK; Jain A; Katare OP; Singh B
    Biomed Chromatogr; 2018 May; 32(5):e4169. PubMed ID: 29244215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a HPLC method for 4,7-phenanthroline-5,6-dione I and identification of its major impurity by HPLC-MS-APCI.
    Shabir GA; Forrow NJ
    J Chromatogr Sci; 2005 Apr; 43(4):207-12. PubMed ID: 15975237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues.
    Huang J; Gautam N; Bathena SP; Roy U; McMillan J; Gendelman HE; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2332-8. PubMed ID: 21752731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Analytical Quality by Design (AQbD) Approach for the Development and Validation of Bioanalytical Liquid Chromatography Method for Estimation of Valsartan.
    Bandopadhyay S; Beg S; Katare OP; Sharma T; Singh B
    J Chromatogr Sci; 2020 Jul; 58(7):606-621. PubMed ID: 32706387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of RP-UPLC method for the determination of darifenacin hydrobromide, its related compounds and its degradation products using design of experiments.
    Murthy MV; Krishnaiah Ch; Srinivas K; Rao KS; Kumar NR; Mukkanti K
    J Pharm Biomed Anal; 2013 Jan; 72():40-50. PubMed ID: 23146225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.
    Colombo S; Beguin A; Telenti A; Biollaz J; Buclin T; Rochat B; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):259-76. PubMed ID: 15833290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monolithic-phase based on-line extraction approach for determination of pharmaceutical components in human plasma by HPLC-MS/MS and a comparison with liquid-liquid extraction.
    Naxing Xu R; Fan L; Kim GE; El-Shourbagy TA
    J Pharm Biomed Anal; 2006 Feb; 40(3):728-36. PubMed ID: 16289933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.